{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:28:32Z","timestamp":1786692512178,"version":"build-2736575974"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00644-8","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:51:45Z","timestamp":1786690305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic stellate cells in alcoholic liver cirrhosis: mechanisms of fibrogenesis, plasticity, and fibrosis reversal"],"prefix":"10.1007","volume":"34","author":[{"given":"Aditya","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-0069","authenticated-orcid":false,"given":"Sourabh","family":"Kosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"644_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","volume":"392","author":"MG Griswold","year":"2018","unstructured":"Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:1015\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(18)31310-2.","journal-title":"Lancet"},{"key":"644_CR2","first-page":"478","volume-title":"Global status report on alcohol and health 2018 Geneva","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global status report on alcohol and health 2018 Geneva. Switzerland: World Health Organization; 2018. p. 478. WhoInt 2018."},{"key":"644_CR3","doi-asserted-by":"publisher","first-page":"617311","DOI":"10.3389\/FPUBH.2021.617311\/PDF","volume":"9","author":"K Balasubramani","year":"2021","unstructured":"Balasubramani K, Paulson W, Chellappan S, Ramachandran R, Behera SK, Balabaskaran Nina P, Epidemiology. Hot Spots, and Sociodemographic Risk Factors of Alcohol Consumption in Indian Men and Women: Analysis of National Family Health Survey-4 (2015-16), a Nationally Representative Cross-Sectional Study. Front Public Health. 2021;9:617311. https:\/\/doi.org\/10.3389\/FPUBH.2021.617311\/PDF.","journal-title":"Front Public Health"},{"key":"644_CR4","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/J.CLINRE.2015.06.015","volume":"39","author":"M Sun","year":"2015","unstructured":"Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 2015;39:S60\u20133. https:\/\/doi.org\/10.1016\/J.CLINRE.2015.06.015.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"644_CR5","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/J.JHEPR.2024.101223","volume":"7","author":"V Merens","year":"2025","unstructured":"Merens V, Knetemann E, G\u00fcrb\u00fcz E, De Smet V, Messaoudi N, Reynaert H, et al. Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies. JHEP Rep. 2025;7:101223. https:\/\/doi.org\/10.1016\/J.JHEPR.2024.101223.","journal-title":"JHEP Rep"},{"key":"644_CR6","doi-asserted-by":"publisher","unstructured":"Wang X, Wang Y, Bai B, Shaha A, Bao W, He L, et al. PKM\u03b6, a Brain-specific PKC\u03b6 Isoform, is Required for Glycolysis and Myofibroblastic Activation of Hepatic Stellate Cells. CMGH. 2025;19. https:\/\/doi.org\/10.1016\/J.JCMGH.2024.101429\/ASSET\/02328AE0-163B-47D7-896E-1D5F4447B178\/MAIN.ASSETS\/GR11.JPG.","DOI":"10.1016\/J.JCMGH.2024.101429\/ASSET\/02328AE0-163B-47D7-896E-1D5F4447B178\/MAIN.ASSETS\/GR11.JPG"},{"key":"644_CR7","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/WJG.V20.I47.17756","volume":"20","author":"E Ceni","year":"2014","unstructured":"Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterology: WJG. 2014;20:17756. https:\/\/doi.org\/10.3748\/WJG.V20.I47.17756.","journal-title":"World J Gastroenterology: WJG"},{"key":"644_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/PHYSREV.00013.2007\/ASSET","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372. https:\/\/doi.org\/10.1152\/PHYSREV.00013.2007\/ASSET\/IMAGES\/LARGE\/Z9J0010824540008.JPEG.","journal-title":"Physiol Rev"},{"key":"644_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Reviews Gastroenterol Hepatol 2017. 2017;14:7. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Reviews Gastroenterol Hepatol 2017"},{"key":"644_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127:55\u201364. https:\/\/doi.org\/10.1172\/JCI88881.","journal-title":"J Clin Invest"},{"key":"644_CR11","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nat 2019. 2019;575:7783. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nat 2019"},{"key":"644_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/NRI.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306\u201321. https:\/\/doi.org\/10.1038\/NRI.2017.11. ;SUBJMETA=1591,250,2504,342,631;KWRD=KUPFFER+CELLS,MONOCYTES+AND+MACROPHAGES.","journal-title":"Nat Rev Immunol"},{"key":"644_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 2013. 2013;4:1. https:\/\/doi.org\/10.1038\/ncomms3823.","journal-title":"Nat Commun 2013"},{"key":"644_CR14","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1111\/J.1440-1746","volume":"22","author":"T Kisseleva","year":"2007","unstructured":"Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol (Australia). 2007;22:S73\u20138. https:\/\/doi.org\/10.1111\/J.1440-1746. 2006.04658.X;SUBPAGE:STRING:ABSTRACT;WEBSITE:WEBSITE:PERICLES;REQUESTEDJOURNAL:JOURNAL:14401746;WGROUP:STRING:PUBLICATION.","journal-title":"J Gastroenterol Hepatol (Australia)"},{"key":"644_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/HEP.28644\/SUPPINFO","volume":"64","author":"W Seo","year":"2016","unstructured":"Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by \u03b3\u03b4 T cells in liver fibrosis. Hepatology. 2016;64:616\u201331. https:\/\/doi.org\/10.1002\/HEP.28644\/SUPPINFO.","journal-title":"Hepatology"},{"key":"644_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/HEP.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology. 2015;61:1066\u201379. https:\/\/doi.org\/10.1002\/HEP.27332. ;JOURNAL:JOURNAL:15273350;WGROUP:STRING:PUBLICATION.","journal-title":"Hepatology"},{"key":"644_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/J.1582-4934","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399. https:\/\/doi.org\/10.1111\/J.1582-4934. 2006.TB00292.X;CTYPE:STRING:JOURNAL.","journal-title":"J Cell Mol Med"},{"key":"644_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/J.MATBIO.2018.04.006","volume":"68\u201369","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO. Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68\u201369:435\u201351. https:\/\/doi.org\/10.1016\/J.MATBIO.2018.04.006.","journal-title":"Matrix Biol"},{"key":"644_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318. https:\/\/doi.org\/10.1172\/JCI24282.","journal-title":"J Clin Invest"},{"key":"644_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/HEP.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatology. 2008;47:1394\u2013400. https:\/\/doi.org\/10.1002\/HEP.22193. ;JOURNAL:JOURNAL:15273350;WGROUP:STRING:PUBLICATION.","journal-title":"Hepatology"},{"key":"644_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/J.JHEP.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis \u2013 a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol. 2007;46:955\u201375. https:\/\/doi.org\/10.1016\/J.JHEP.2007.02.003.","journal-title":"J Hepatol"},{"key":"644_CR22","doi-asserted-by":"publisher","first-page":"11069","DOI":"10.1074\/JBC.M111490200","volume":"277","author":"FR Murphy","year":"2002","unstructured":"Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJP, et al. Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition: IMPLICATIONS FOR REVERSIBILITY OF LIVER FIBROSIS. J Biol Chem. 2002;277:11069\u201376. https:\/\/doi.org\/10.1074\/JBC.M111490200.","journal-title":"J Biol Chem"},{"key":"644_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","volume":"128","author":"J Herrera","year":"2018","unstructured":"Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J Clin Invest. 2018;128:45\u201353. https:\/\/doi.org\/10.1172\/JCI93557.","journal-title":"J Clin Invest"},{"key":"644_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.GDE.2004.12.002","volume":"15","author":"E Sahai","year":"2005","unstructured":"Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev. 2005;15:87\u201396. https:\/\/doi.org\/10.1016\/J.GDE.2004.12.002.","journal-title":"Curr Opin Genet Dev"},{"key":"644_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S00018-011-0783-6","volume":"68","author":"KS Midwood","year":"2011","unstructured":"Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci 2011. 2011;68:19. https:\/\/doi.org\/10.1007\/S00018-011-0783-6.","journal-title":"Cell Mol Life Sci 2011"},{"key":"644_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1096\/FJ.14-268425;WGROUP:STRING:PUBLICATION","volume":"30","author":"SB Liu","year":"2016","unstructured":"Liu SB, Ikenaga N, Peng ZW, Sverdlov DY, Greenstein A, Smith V, et al. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. FASEB J. 2016;30:1599\u2013609. https:\/\/doi.org\/10.1096\/FJ.14-268425;WGROUP:STRING:PUBLICATION.","journal-title":"FASEB J"},{"key":"644_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/HEP.27376","volume":"61","author":"LD Deleve","year":"2015","unstructured":"Deleve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology. 2015;61:1740\u20136. https:\/\/doi.org\/10.1002\/HEP.27376. ;JOURNAL:JOURNAL:15273350;WGROUP:STRING:PUBLICATION.","journal-title":"Hepatology"},{"key":"644_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0016-5085(63)80130-4","volume":"44","author":"F Schaffner","year":"1963","unstructured":"Schaffner F, Popper H. Capillarization of Hepatic Sinusoids in Man. Gastroenterology. 1963;44:239\u201342. https:\/\/doi.org\/10.1016\/S0016-5085(63)80130-4.","journal-title":"Gastroenterology"},{"key":"644_CR29","unstructured":"Xie G, Wang X, Wang L, Wang L, Gastroenterology RA-, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA. LD DeLeveGastroenterology, 2012\u2022Elsevier n.d."},{"key":"644_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/S-0030-1255355\/ID\/20\/BIB","volume":"30","author":"O Rosmorduc","year":"2010","unstructured":"Rosmorduc O, Housset C, Hypoxia. A link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis. 2010;30:258\u201370. https:\/\/doi.org\/10.1055\/S-0030-1255355\/ID\/20\/BIB.","journal-title":"Semin Liver Dis"},{"key":"644_CR31","doi-asserted-by":"publisher","unstructured":"Medina J, Arroyo AG, S\u00e1nchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Wiley Online LibraryJ Medina, Arroyo AG, S\u00e1nchez-Madrid F, Moreno\u2010OteroHepatology R. 2004\u2022Wiley Online Library 2004;39:1185\u201395. https:\/\/doi.org\/10.1002\/HEP.20193","DOI":"10.1002\/HEP.20193"},{"key":"644_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/J.1478-3231.2010.02205","volume":"30","author":"BL Copple","year":"2010","unstructured":"Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-\u03b2-dependent mechanisms. Liver Int. 2010;30:669\u201382. https:\/\/doi.org\/10.1111\/J.1478-3231.2010.02205. .X;REQUESTEDJOURNAL:JOURNAL:14783231;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Liver Int"},{"key":"644_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1152\/AJPGI.90368.2008\/ASSET","volume":"296","author":"JOK Moon","year":"2009","unstructured":"Moon JOK, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia-inducible factor-1\u03b1-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:582\u201392. https:\/\/doi.org\/10.1152\/AJPGI.90368.2008\/ASSET\/IMAGES\/LARGE\/ZH30030953250012.JPEG.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"644_CR34","doi-asserted-by":"publisher","unstructured":"Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Hepatic recruitment of the inflammatory Gr1\u2009+\u2009monocyte subset upon liver injury promotes hepatic fibrosis. Wiley Online LibraryKR Karlmark, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, MeradHepatology M et al. 2009\u2022Wiley Online Library 2009;50:261\u201374. https:\/\/doi.org\/10.1002\/HEP.22950","DOI":"10.1002\/HEP.22950"},{"key":"644_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/HEP.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Wiley Online LibraryE Seki, DA BrennerHepatology. 2008\u2022Wiley Online Libr. 2008;48:322\u201335. https:\/\/doi.org\/10.1002\/HEP.22306.","journal-title":"2008\u2022Wiley Online Libr"},{"key":"644_CR36","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3748\/WJG.V16.I11.1321","volume":"16","author":"G Szabo","year":"2010","unstructured":"Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterology: WJG. 2010;16:1321. https:\/\/doi.org\/10.3748\/WJG.V16.I11.1321.","journal-title":"World J Gastroenterology: WJG"},{"key":"644_CR37","doi-asserted-by":"crossref","unstructured":"Su T, Yang Y, Lai S, Jeong J, \u2026 YJ-C and molecular, 2021 undefined. Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis.ElsevierT Su, Y Yang, S Lai, J Jeong, Y Jung, M McConnell, T Utsumi, Y IwakiriCellular and Molecular Gastroenterology and Hepatology, 2021\u2022Elsevier n.d.","DOI":"10.1101\/2020.03.18.997452"},{"key":"644_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.TIPS.2020.11.004\/ASSET\/1B38F723-1F69-48EE-95FE-BFC95B0A513D\/MAIN.ASSETS\/B2.SML","volume":"42","author":"D Cort\u00e9s-Selva","year":"2021","unstructured":"Cort\u00e9s-Selva D, Dasgupta B, Singh S, Grewal IS. Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy. Trends Pharmacol Sci. 2021;42:45\u201359. https:\/\/doi.org\/10.1016\/J.TIPS.2020.11.004\/ASSET\/1B38F723-1F69-48EE-95FE-BFC95B0A513D\/MAIN.ASSETS\/B2.SML.","journal-title":"Trends Pharmacol Sci"},{"key":"644_CR39","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9\/ASSET\/7733AF50-27EC-4033-8A7C-F205DF26F8C2\/MAIN.ASSETS\/GR4.SML","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(08)60383-9\/ASSET\/7733AF50-27EC-4033-8A7C-F205DF26F8C2\/MAIN.ASSETS\/GR4.SML.","journal-title":"Lancet"},{"key":"644_CR40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(14)60121-5\/ASSET\/C7192B20-5C9D-436A-A60E-FFA2A78BEAF6\/MAIN.ASSETS\/GR5.SML.","journal-title":"Lancet"},{"key":"644_CR41","doi-asserted-by":"crossref","unstructured":"Ellis E. hepatology DM-J of, 2012 undefined. Clinical evidence for the regression of liver fibrosis. Elsevier n.d;","DOI":"10.1016\/j.jhep.2011.09.024"},{"key":"644_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/J.JHEP.2005.10.013\/ASSET\/0BB26442-18F8-4022-A61E-42DDB3D1E467\/MAIN.ASSETS\/GR7.JPG","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44:217\u201331. https:\/\/doi.org\/10.1016\/J.JHEP.2005.10.013\/ASSET\/0BB26442-18F8-4022-A61E-42DDB3D1E467\/MAIN.ASSETS\/GR7.JPG.","journal-title":"J Hepatol"},{"key":"644_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Reviews Immunol 2014. 2014;14:3. https:\/\/doi.org\/10.1038\/nri3623.","journal-title":"Nat Reviews Immunol 2014"},{"key":"644_CR44","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/J.GASTRO.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of Hepatic Fibrogenesis. Gastroenterology. 2008;134:1655\u201369. https:\/\/doi.org\/10.1053\/J.GASTRO.2008.03.003.","journal-title":"Gastroenterology"},{"key":"644_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117:539\u201348. https:\/\/doi.org\/10.1172\/JCI30542.","journal-title":"J Clin Invest"},{"key":"644_CR46","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/J.1360-0443","volume":"104","author":"C Verrill","year":"2009","unstructured":"Verrill C, Markham H, Templeton A, Carr NJ, Sheron N. Alcohol-related cirrhosis - Early abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 2009;104:768\u201374. https:\/\/doi.org\/10.1111\/J.1360-0443. 2009.02521.X;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Addiction"},{"key":"644_CR47","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(96)07642-8.","journal-title":"Lancet"},{"key":"644_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3181\/0707-MR","volume":"233","author":"T Kisseleva","year":"2008","unstructured":"Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med. 2008;233:109\u201322. https:\/\/doi.org\/10.3181\/0707-MR. -190;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Exp Biol Med"},{"key":"644_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/J.ALCOHOL.2012.08.004","volume":"46","author":"E Brandon-Warner","year":"2012","unstructured":"Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH. Rodent models of alcoholic liver disease: of mice and men. Alcohol. 2012;46:715\u201325. https:\/\/doi.org\/10.1016\/J.ALCOHOL.2012.08.004.","journal-title":"Alcohol"},{"key":"644_CR50","doi-asserted-by":"publisher","first-page":"12928","DOI":"10.1074\/JBC.M700554200","volume":"282","author":"YP Han","year":"2007","unstructured":"Han YP, Yan C, Zhou L, Qin L, Tsukamoto H. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem. 2007;282:12928\u201339. https:\/\/doi.org\/10.1074\/JBC.M700554200.","journal-title":"J Biol Chem"},{"key":"644_CR51","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/WJG.V22.I48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22:10512. https:\/\/doi.org\/10.3748\/WJG.V22.I48.10512.","journal-title":"World J Gastroenterol"},{"key":"644_CR52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/GUTJNL-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341. https:\/\/doi.org\/10.1136\/GUTJNL-2014-306842.","journal-title":"Gut"},{"key":"644_CR53","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/HEP.25993","volume":"57","author":"J Boursier","year":"2013","unstructured":"Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-HubertHepatology I, et al. 2013\u2022Wiley Online Libr. 2013;57:1182\u201391. https:\/\/doi.org\/10.1002\/HEP.25993.","journal-title":"2013\u2022Wiley Online Libr"},{"key":"644_CR54","doi-asserted-by":"publisher","first-page":"14626","DOI":"10.3748\/WJG.V20.I40.14626","volume":"20","author":"S Mueller","year":"2014","unstructured":"Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterology: WJG. 2014;20:14626. https:\/\/doi.org\/10.3748\/WJG.V20.I40.14626.","journal-title":"World J Gastroenterology: WJG"},{"key":"644_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/0148607195019004258","volume":"19","author":"CL Mendenhall","year":"1995","unstructured":"Mendenhall CL, Roselle GA, Weesner RE, Moritz TE, Nemchausky BA, Henderson WG, et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. J Parenter Enteral Nutr. 1995;19:258\u201365. https:\/\/doi.org\/10.1177\/0148607195019004258.","journal-title":"J Parenter Enteral Nutr"},{"key":"644_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/JGH.12030","volume":"28","author":"ES Orman","year":"2013","unstructured":"Orman ES, Odena G, Bataller R. Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol. 2013;28:77\u201384. https:\/\/doi.org\/10.1111\/JGH.12030.","journal-title":"J Gastroenterol Hepatol"},{"key":"644_CR57","doi-asserted-by":"publisher","unstructured":"Du K, Jun JH, Dutta RK, Diehl AM. Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology. Hepatol Commun. 2024;8. https:\/\/doi.org\/10.1097\/HC9.0000000000000411.","DOI":"10.1097\/HC9.0000000000000411"},{"key":"644_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/J.JHEP.2015.04.011","volume":"63","author":"I Mannaerts","year":"2015","unstructured":"Mannaerts I, Leite SB, Verhulst S, Claerhout S, Eysackers N, Thoen LFR, et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679\u201388. https:\/\/doi.org\/10.1016\/J.JHEP.2015.04.011.","journal-title":"J Hepatol"},{"key":"644_CR59","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1074\/jbc.M310284200","volume":"279","author":"S Hazra","year":"2004","unstructured":"Hazra S, Xiong S, Wang J, Rippe RA, Chatterjee VKK, Tsukamoto H. Peroxisome Proliferator-activated Receptor \u03b3 Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells. J Biol Chem. 2004;279:11392\u2013401. https:\/\/doi.org\/10.1074\/jbc.M310284200.","journal-title":"J Biol Chem"},{"key":"644_CR60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/ANNUREV.MED.57.121304.131428\/CITE\/REFWORKS","volume":"57","author":"SW Beaven","year":"2006","unstructured":"Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia. Annu Rev Med. 2006;57:313\u201329. https:\/\/doi.org\/10.1146\/ANNUREV.MED.57.121304.131428\/CITE\/REFWORKS.","journal-title":"Annu Rev Med"},{"key":"644_CR61","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.18632\/ONCOTARGET.2621","volume":"6","author":"J Wang","year":"2014","unstructured":"Wang J, Chu ESH, Chen HY, Man K, Go MYY, Huang XR, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget. 2014;6:7325. https:\/\/doi.org\/10.18632\/ONCOTARGET.2621.","journal-title":"Oncotarget"},{"key":"644_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126662","volume":"25","author":"R Teschke","year":"2024","unstructured":"Teschke R. Copper, iron, cadmium, and arsenic, all generated in the universe: elucidating their environmental impact risk on human health including clinical liver injury. Int J Mol Sci. 2024;25:6662. https:\/\/doi.org\/10.3390\/ijms25126662.","journal-title":"Int J Mol Sci"},{"key":"644_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10534-025-00748-9","volume":"39","author":"Y Ma","year":"2026","unstructured":"Ma Y, Pu Y, Chen H, Zhou L, Yang B, Huang X, et al. The pathogenesis of liver fibrosis in Wilson\u2019s disease: hepatocyte injury and regulation mediated by copper metabolism dysregulation. Biometals. 2026;39:1\u201323. https:\/\/doi.org\/10.1007\/s10534-025-00748-9.","journal-title":"Biometals"},{"key":"644_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/acs.chemrev.4c00577","volume":"125","author":"R Rodriguez","year":"2025","unstructured":"Rodriguez R, M\u00fcller S, Colombeau L, Solier S, Sindikubwabo F, Ca\u00f1eque T. Metal Ion Signaling in Biomedicine. Chem Rev. 2025;125:660\u2013744. https:\/\/doi.org\/10.1021\/acs.chemrev.4c00577.","journal-title":"Chem Rev"},{"key":"644_CR65","doi-asserted-by":"publisher","unstructured":"Childs BG, Durik M, Baker DJ, Van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nature Medicine. 2015 21:12 2015;21:1424\u201335. https:\/\/doi.org\/10.1038\/nm.4000","DOI":"10.1038\/nm.4000"},{"key":"644_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.GDE.2010.10.005","volume":"21","author":"J Campisi","year":"2011","unstructured":"Campisi J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev. 2011;21:107\u201312. https:\/\/doi.org\/10.1016\/J.GDE.2010.10.005.","journal-title":"Curr Opin Genet Dev"},{"key":"644_CR67","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/S10522-013-9473-0\/METRICS","volume":"14","author":"A Sagiv","year":"2013","unstructured":"Sagiv A, Krizhanovsky V. Immunosurveillance of senescent cells: The bright side of the senescence program. Biogerontology. 2013;14:617\u201328. https:\/\/doi.org\/10.1007\/S10522-013-9473-0\/METRICS.","journal-title":"Biogerontology"},{"key":"644_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34605","volume":"6","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa H, Iguchi G, Fukuoka H, Takahashi M, Suda K, Bando H, et al. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci Rep 2016. 2016;6:1. https:\/\/doi.org\/10.1038\/srep34605.","journal-title":"Sci Rep 2016"},{"key":"644_CR69","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1172\/JCI95149","volume":"128","author":"Y Ovadya","year":"2018","unstructured":"Ovadya Y, Krizhanovsky V. Strategies targeting cellular senescence. J Clin Invest. 2018;128:1247\u201354. https:\/\/doi.org\/10.1172\/JCI95149.","journal-title":"J Clin Invest"},{"key":"644_CR70","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/NRD.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs BG, Gluscevic M, Baker DJ, Laberge RM, Marquess D, Dananberg J, et al. Senescent cells: An emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16:718\u201335. https:\/\/doi.org\/10.1038\/NRD.2017.116. ;SUBJMETA=154,443,509,631,7,80;KWRD=AGEING,DRUG+DISCOVERY,SENESCENCE.","journal-title":"Nat Rev Drug Discov"},{"key":"644_CR71","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nat 2020. 2020;583:7814. https:\/\/doi.org\/10.1038\/s41586-020-2403-9.","journal-title":"Nat 2020"},{"key":"644_CR72","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1101\/GAD.343129.120","volume":"34","author":"J Birch","year":"2020","unstructured":"Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34:1565\u201376. https:\/\/doi.org\/10.1101\/GAD.343129.120.","journal-title":"Genes Dev"},{"key":"644_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.EBIOM.2017.04.013\/ASSET\/A66DB77A-7E50-4464-BB75-51C97F7A3EF7\/MAIN.ASSETS\/GR1.JPG","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T, Cellular Senescence A, Translational Perspective. EBioMedicine. 2017;21:21\u20138. https:\/\/doi.org\/10.1016\/J.EBIOM.2017.04.013\/ASSET\/A66DB77A-7E50-4464-BB75-51C97F7A3EF7\/MAIN.ASSETS\/GR1.JPG.","journal-title":"EBioMedicine"},{"key":"644_CR74","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1053\/J.GASTRO.2008.07.065","volume":"135","author":"K Taura","year":"2008","unstructured":"Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology. 2008;135:1729\u201338. https:\/\/doi.org\/10.1053\/J.GASTRO.2008.07.065.","journal-title":"Gastroenterology"},{"key":"644_CR75","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/J.GASTRO.2012.06.036","volume":"143","author":"JS Troeger","year":"2012","unstructured":"Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC, et al. Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice. Gastroenterology. 2012;143:1073\u2013e108322. https:\/\/doi.org\/10.1053\/J.GASTRO.2012.06.036.","journal-title":"Gastroenterology"},{"key":"644_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S11010-013-1895-0\/METRICS","volume":"388","author":"X Sun","year":"2014","unstructured":"Sun X, He Y, Ma TT, Huang C, Zhang L, Li J. Participation of miR-200a in TGF-\u03b21-mediated hepatic stellate cell activation. Mol Cell Biochem. 2014;388:11\u201323. https:\/\/doi.org\/10.1007\/S11010-013-1895-0\/METRICS.","journal-title":"Mol Cell Biochem"},{"key":"644_CR77","doi-asserted-by":"publisher","unstructured":"Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 2016. 7(1 2016):1\u201311. https:\/\/doi.org\/10.1038\/ncomms11190.","DOI":"10.1038\/ncomms11190"},{"key":"644_CR78","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/J.GASTRO.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572\u201385. https:\/\/doi.org\/10.1053\/J.GASTRO.2011.09.002.","journal-title":"Gastroenterology"},{"key":"644_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0096864","volume":"9","author":"S Bala","year":"2014","unstructured":"Bala S, Marcos M, Gattu A, Catalano D, Szabo G. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS One. 2014;9:e96864. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0096864.","journal-title":"PLoS One"},{"key":"644_CR80","doi-asserted-by":"publisher","unstructured":"Chen P, St\u00e4rkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Wiley Online LibraryP Chen, St\u00e4rkel P, Turner JR, Ho SB, SchnablHepatology B. 2015\u2022Wiley Online Library 2015;61:883\u201394. https:\/\/doi.org\/10.1002\/HEP.27489","DOI":"10.1002\/HEP.27489"},{"key":"644_CR81","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ACER.12704","volume":"39","author":"P Hartmann","year":"2015","unstructured":"Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: The gut microbiome and liver cross talk. Alcohol Clin Exp Res. 2015;39:763\u201375. https:\/\/doi.org\/10.1111\/ACER.12704. ;CTYPE:STRING:JOURNAL.","journal-title":"Alcohol Clin Exp Res"},{"key":"644_CR82","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1113\/JPHYSIOL.2011.219691","volume":"590","author":"E Seki","year":"2012","unstructured":"Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut. J Physiol. 2012;590:447\u201358. https:\/\/doi.org\/10.1113\/JPHYSIOL.2011.219691. ;SUBPAGE:STRING:FULL.","journal-title":"J Physiol"},{"key":"644_CR83","doi-asserted-by":"publisher","unstructured":"Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Wiley Online LibraryYH Paik, Schwabe RF, Bataller R, Russo MP, Jobin C, BrennerHepatology DA. 2003\u2022Wiley Online Library 2003;37:1043\u201355. https:\/\/doi.org\/10.1053\/JHEP.2003.50182","DOI":"10.1053\/JHEP.2003.50182"},{"key":"644_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/853175","author":"A Ambade","year":"2012","unstructured":"Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol. 2012. https:\/\/doi.org\/10.1155\/2012\/853175.","journal-title":"Int J Hepatol"},{"key":"644_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.35946\/arcr.v37.2.01","volume":"37","author":"G Szabo","year":"2015","unstructured":"Szabo G, Saha B. Alcohol\u2019s Effect on Host Defense. Alcohol Res. 2015;37:159.","journal-title":"Alcohol Res"},{"key":"644_CR86","doi-asserted-by":"publisher","first-page":"185","DOI":"10.35946\/arcr.v37.2.04","volume":"37","author":"S Pasala","year":"2015","unstructured":"Pasala S, Barr T, Messaoudi I. Impact of Alcohol Abuse on the Adaptive Immune System. Alcohol Res. 2015;37:185.","journal-title":"Alcohol Res"},{"key":"644_CR87","doi-asserted-by":"publisher","first-page":"345803","DOI":"10.1155\/2011\/345803","volume":"2011","author":"F Tacke","year":"2011","unstructured":"Tacke F, Hammerich L, Heymann F. Role of IL-17 and Th17 Cells in Liver Diseases. J Immunol Res. 2011;2011:345803. https:\/\/doi.org\/10.1155\/2011\/345803.","journal-title":"J Immunol Res"},{"key":"644_CR88","doi-asserted-by":"crossref","unstructured":"Tacke F, hepatology of HZ-J. 2014 undefined. Macrophage heterogeneity in liver injury and fibrosis. Elsevier n.d.","DOI":"10.1016\/j.jhep.2013.12.025"},{"key":"644_CR89","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/J.IMMUNI.2020.04.001\/ATTACHMENT\/ED02BDDC-8F39-485D-894E-E5A4E20A0F18\/MMC8.PDF","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman JS, Troutman TD, Sakai M, Gola A, Spann NJ, Bennett H, et al. Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic. Steatohepatitis Immun. 2020;52:1057\u2013e10747. https:\/\/doi.org\/10.1016\/J.IMMUNI.2020.04.001\/ATTACHMENT\/ED02BDDC-8F39-485D-894E-E5A4E20A0F18\/MMC8.PDF.","journal-title":"Steatohepatitis Immun"},{"key":"644_CR90","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/GUTJNL-2018-316510","volume":"68","author":"CJ Lim","year":"2019","unstructured":"Lim CJ, Lee YH, Pan L, Lai L, Chua C, Wasser M, et al. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Gut. 2019;68:916\u201327. https:\/\/doi.org\/10.1136\/GUTJNL-2018-316510.","journal-title":"Gut"},{"issue":"4","key":"644_CR91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","volume":"12","author":"A Louvet","year":"2015","unstructured":"Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2015.35.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"644_CR92","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso G, Cassader M, Gambino R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Reviews Drug Discovery 2016. 2016;15:4. https:\/\/doi.org\/10.1038\/nrd.2015.3.","journal-title":"Nat Reviews Drug Discovery 2016"},{"key":"644_CR93","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/HEP4.1271","volume":"2","author":"C Garc\u00eda-Ruiz","year":"2018","unstructured":"Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Mitochondrial oxidative stress and antioxidants balance in fatty liver disease. Wiley Online LibraryC Garc\u00eda-Ruiz, JC Fern\u00e1ndez\u2010ChecaHepatology Communications. 2018\u2022Wiley Online Libr. 2018;2:1425\u201339. https:\/\/doi.org\/10.1002\/HEP4.1271.","journal-title":"2018\u2022Wiley Online Libr"},{"key":"644_CR94","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/J.GASTRO.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155:629\u201347. https:\/\/doi.org\/10.1053\/J.GASTRO.2018.06.083.","journal-title":"Gastroenterology"},{"key":"644_CR95","doi-asserted-by":"crossref","unstructured":"Xu R, Zhang Z, Wang FS. Liver fibrosis: Mechanisms of immune-mediated liver injury. Cell Mol Immunol. 2012;9:296\u2013301. https:\/\/doi.org\/10.1038\/CMI.2011.53;KWRD=BIOMEDICINE.","DOI":"10.1038\/cmi.2011.53"},{"key":"644_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.MAM.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355. https:\/\/doi.org\/10.1016\/J.MAM.2018.09.002.","journal-title":"Mol Aspects Med"},{"key":"644_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut\u2013liver axis and the intersection with the microbiome. Nat Reviews Gastroenterol Hepatol 2018. 2018;15:7. https:\/\/doi.org\/10.1038\/s41575-018-0011-z.","journal-title":"Nat Reviews Gastroenterol Hepatol 2018"},{"key":"644_CR98","doi-asserted-by":"publisher","first-page":"1574385","DOI":"10.3389\/FPHAR.2025.1574385\/FULL","volume":"16","author":"X Zeng","year":"2025","unstructured":"Zeng X, Huang D, Zhu Z, Cai Q, Yang Y, Lu H, et al. Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective. Front Pharmacol. 2025;16:1574385. https:\/\/doi.org\/10.3389\/FPHAR.2025.1574385\/FULL.","journal-title":"Front Pharmacol"},{"key":"644_CR99","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/14656566.2020.1744564","volume":"21","author":"Y Sumida","year":"2020","unstructured":"Sumida Y, Yoneda M, Ogawa Y, Yoneda M, Okanoue T, Nakajima A. Current and new pharmacotherapy options for non-alcoholic steatohepatitis. Expert Opin Pharmacother. 2020;21:953\u201367. https:\/\/doi.org\/10.1080\/14656566.2020.1744564.","journal-title":"Expert Opin Pharmacother"},{"key":"644_CR100","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/J.CGH.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee QM, Neuschwander-Tetri BA, Wai-Sun Wong V, Abdelmalek MF, Rodriguez-Araujo G, Landgren H, et al. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study. Clin Gastroenterol Hepatol. 2024;22:124\u2013e1341. https:\/\/doi.org\/10.1016\/J.CGH.2023.04.003.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"644_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.105922","author":"QM Anstee","year":"2020","unstructured":"Anstee QM, Neuschwander-Tetri BA, Wong VWS, Abdelmalek MF, Younossi ZM, Yuan J, et al. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA phase 3 study design. Contemp Clin Trials. 2020. https:\/\/doi.org\/10.1016\/j.cct.2019.105922.","journal-title":"Contemp Clin Trials"},{"key":"644_CR102","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3350\/CMH.2023.0356","volume":"30","author":"Y Chang","year":"2023","unstructured":"Chang Y, Jeong SW, Jang JY. Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease. Clin Mol Hepatol. 2023;30:129. https:\/\/doi.org\/10.3350\/CMH.2023.0356.","journal-title":"Clin Mol Hepatol"},{"key":"644_CR103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/J.JHEP.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, Wong VWS, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials. J Hepatol. 2020;73:26\u201339. https:\/\/doi.org\/10.1016\/J.JHEP.2020.02.027.","journal-title":"J Hepatol"},{"key":"644_CR104","unstructured":"Harrison S, Abdelmalek M, Caldwell S, Gastroenterology MS-, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R. EJ LawitzGastroenterology, 2018\u2022Elsevier n.d."},{"key":"644_CR105","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(19)33041-7.","journal-title":"Lancet"},{"key":"644_CR106","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jhep.2019.12.010","volume":"72","author":"G Garcia-Tsao","year":"2020","unstructured":"Garcia-Tsao G, Bosch J, Kayali Z, Harrison SA, Abdelmalek MF, Lawitz E, et al. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. J Hepatol. 2020;72:885\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2019.12.010.","journal-title":"J Hepatol"},{"key":"644_CR107","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/J.JHEP.2018.12.003","volume":"70","author":"C Lackner","year":"2019","unstructured":"Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70:294\u2013304. https:\/\/doi.org\/10.1016\/J.JHEP.2018.12.003.","journal-title":"J Hepatol"},{"key":"644_CR108","doi-asserted-by":"publisher","unstructured":"Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49. https:\/\/doi.org\/10.2147\/hmer.s7394","DOI":"10.2147\/hmer.s7394"},{"key":"644_CR109","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/J.GASTRO.2004.08.052","volume":"127","author":"WMC Rosenberg","year":"2004","unstructured":"Rosenberg WMC, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology. 2004;127:1704\u201313. https:\/\/doi.org\/10.1053\/J.GASTRO.2004.08.052.","journal-title":"Gastroenterology"},{"key":"644_CR110","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/LIV.12700","volume":"35","author":"MJ Nielsen","year":"2015","unstructured":"Nielsen MJ, Veidal SS, Karsdal MA, \u00d8rsnes-Leeming DJ, Vainer B, Gardner SD, et al. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int. 2015;35:429\u201337. https:\/\/doi.org\/10.1111\/LIV.12700.","journal-title":"Liver Int"},{"key":"644_CR111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/J.1365-2893.2009.01263","volume":"18","author":"J Parkes","year":"2011","unstructured":"Parkes J, Guha IN, Roderick P, Harris S, Cross R, Manos MM, et al. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat. 2011;18:23\u201331. https:\/\/doi.org\/10.1111\/J.1365-2893.2009.01263. .X;JOURNAL:JOURNAL:13652893;WGROUP:STRING:PUBLICATION.","journal-title":"J Viral Hepat"},{"key":"644_CR112","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1055\/S-0035-1550059\/ID\/JR00794-20\/BIB","volume":"35","author":"K Patel","year":"2015","unstructured":"Patel K, Bedossa P, Castera L. Diagnosis of liver fibrosis: Present and future. Semin Liver Dis. 2015;35:166\u201383. https:\/\/doi.org\/10.1055\/S-0035-1550059\/ID\/JR00794-20\/BIB.","journal-title":"Semin Liver Dis"},{"key":"644_CR113","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/J.MATBIO.2015.01.004","volume":"44\u201346","author":"S Duarte","year":"2015","unstructured":"Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 2015;44\u201346:147\u201356. https:\/\/doi.org\/10.1016\/J.MATBIO.2015.01.004.","journal-title":"Matrix Biol"},{"key":"644_CR114","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/J.GASTRO.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo G. Gut\u2013Liver Axis in Alcoholic Liver Disease. Gastroenterology. 2015;148:30\u20136. https:\/\/doi.org\/10.1053\/J.GASTRO.2014.10.042.","journal-title":"Gastroenterology"},{"key":"644_CR115","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/J.GASTRO.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156:1264\u201381. https:\/\/doi.org\/10.1053\/J.GASTRO.2018.12.036. .e4.","journal-title":"Gastroenterology"},{"key":"644_CR116","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/J.MRIC.2014.05.001\/ASSET\/5B0B82C1-01E3-4044-9A4B-9147A1A9D7E7\/MAIN.ASSETS\/GR12.SML","volume":"22","author":"SK Venkatesh","year":"2014","unstructured":"Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. Magn Reson Imaging Clin N Am. 2014;22:433\u201346. https:\/\/doi.org\/10.1016\/J.MRIC.2014.05.001\/ASSET\/5B0B82C1-01E3-4044-9A4B-9147A1A9D7E7\/MAIN.ASSETS\/GR12.SML.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"644_CR117","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/LIV.13284\/SUPPINFO","volume":"37","author":"M Pavlides","year":"2017","unstructured":"Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017;37:1065\u201373. https:\/\/doi.org\/10.1111\/LIV.13284\/SUPPINFO.","journal-title":"Liver Int"},{"key":"644_CR118","doi-asserted-by":"publisher","unstructured":"Chen S, Zhuang D, Jia Q, Guo B, Hu G. Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis. Biomater Res. 2024;28. https:\/\/doi.org\/10.34133\/BMR.0042\/SUPPL_FILE\/BMR.0042.F1.DOCX.","DOI":"10.34133\/BMR.0042\/SUPPL_FILE\/BMR.0042.F1.DOCX"},{"key":"644_CR119","doi-asserted-by":"publisher","first-page":"14424","DOI":"10.1073\/PNAS.1508524112","volume":"112","author":"R Weissleder","year":"2015","unstructured":"Weissleder R, Nahrendorf M. Advancing biomedical imaging. Proc Natl Acad Sci U S A. 2015;112:14424\u20138. https:\/\/doi.org\/10.1073\/PNAS.1508524112. ;WGROUP:STRING:PUBLICATION.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"644_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2214\/AJR.09.2601","volume":"193","author":"B Taouli","year":"2009","unstructured":"Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. Am J Roentgenol. 2009;193:14\u201327. https:\/\/doi.org\/10.2214\/AJR.09.2601\/ASSET\/IMAGES\/07_09_2601_12D.JPEG.","journal-title":"Am J Roentgenol"},{"key":"644_CR121","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMRA1610570\/SUPPL_FILE","volume":"377","author":"EB Tapper","year":"2017","unstructured":"Tapper EB, Lok AS-F. Use of Liver Imaging and Biopsy in Clinical Practice. N Engl J Med. 2017;377:756\u201368. https:\/\/doi.org\/10.1056\/NEJMRA1610570\/SUPPL_FILE\/NEJMRA1610570_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"key":"644_CR122","doi-asserted-by":"publisher","DOI":"10.1021\/CBMI.5C00055","author":"X Hu","year":"2025","unstructured":"Hu X, Xu M, Xiao X, Wang N, Zhang Q, Ge J, et al. Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis. Chem Biomedical Imaging. 2025. https:\/\/doi.org\/10.1021\/CBMI.5C00055\/ASSET\/IMAGES\/LARGE\/IM5C00055_0007.JPEG.","journal-title":"Chem Biomedical Imaging"},{"key":"644_CR123","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/BIOS12050342","volume":"12","author":"D Zhao","year":"2022","unstructured":"Zhao D, Cao J, Zhang L, Zhang S, Wu S. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022. Page 342. 2022;12:12:342. https:\/\/doi.org\/10.3390\/BIOS12050342.","journal-title":"Page 342"},{"key":"644_CR124","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3\/ASSET\/FC8C38EC-7B3C-41A9-95F9-167684373E1C\/MAIN.ASSETS\/GR4.SML","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3\/ASSET\/FC8C38EC-7B3C-41A9-95F9-167684373E1C\/MAIN.ASSETS\/GR4.SML.","journal-title":"Lancet"},{"key":"644_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2016","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Reviews Gastroenterol Hepatol 2016. 2016;14:1. https:\/\/doi.org\/10.1038\/nrgastro.2016.147.","journal-title":"Nat Reviews Gastroenterol Hepatol 2016"},{"key":"644_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/J.GASTRO.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389-397.e10. https:\/\/doi.org\/10.1053\/J.GASTRO.2015.04.043.","journal-title":"Gastroenterology"},{"key":"644_CR127","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/J.JHEP.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371. https:\/\/doi.org\/10.1016\/J.JHEP.2018.09.014.","journal-title":"J Hepatol"},{"key":"644_CR128","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/J.JHEP.2005.10.013\/ASSET\/0BB26442-18F8-4022-A61E-42DDB3D1E467\/MAIN.ASSETS\/GR7.JPG","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44:217\u201331. https:\/\/doi.org\/10.1016\/J.JHEP.2005.10.013\/ASSET\/0BB26442-18F8-4022-A61E-42DDB3D1E467\/MAIN.ASSETS\/GR7.JPG.","journal-title":"J Hepatol"},{"key":"644_CR129","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/J.JHEP.2017.11.012","volume":"68","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Surabattula R, Wang XY. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2018;68:238\u201350. https:\/\/doi.org\/10.1016\/J.JHEP.2017.11.012.","journal-title":"J Hepatol"},{"key":"644_CR130","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X\/ASSET\/9AE8B906-E72B-4510-8530-B41534D13390\/MAIN.ASSETS\/GR3.SML","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X\/ASSET\/9AE8B906-E72B-4510-8530-B41534D13390\/MAIN.ASSETS\/GR3.SML.","journal-title":"Lancet"},{"key":"644_CR131","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/J.CELREP.2019.10.024\/ATTACHMENT\/936C42AE-46F5-4EF5-A58F-6C8B14B4E2E5\/MMC6.PDF","volume":"29","author":"R Dobie","year":"2019","unstructured":"Dobie R, Wilson-Kanamori JR, Henderson BEP, Smith JR, Matchett KP, Portman JR, et al. Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis. Cell Rep. 2019;29:1832\u2013e18478. https:\/\/doi.org\/10.1016\/J.CELREP.2019.10.024\/ATTACHMENT\/936C42AE-46F5-4EF5-A58F-6C8B14B4E2E5\/MMC6.PDF.","journal-title":"Cell Rep"},{"key":"644_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Reviews Disease Primers 2018. 2018;4:1. https:\/\/doi.org\/10.1038\/s41572-018-0014-7.","journal-title":"Nat Reviews Disease Primers 2018"},{"key":"644_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.ADDR.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342. https:\/\/doi.org\/10.1016\/J.ADDR.2017.05.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"644_CR134","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/CELLS9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020. Page 875. 2020;9:9:875. https:\/\/doi.org\/10.3390\/CELLS9040875.","journal-title":"Page 875"},{"key":"644_CR135","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5009\/GNL16477","volume":"11","author":"F Stickel","year":"2017","unstructured":"Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017;11:173. https:\/\/doi.org\/10.5009\/GNL16477.","journal-title":"Gut Liver"},{"key":"644_CR136","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/J.JHEP.2009.03.007","volume":"50","author":"P Mandrekar","year":"2009","unstructured":"Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 2009;50:1258\u201366. https:\/\/doi.org\/10.1016\/J.JHEP.2009.03.007.","journal-title":"J Hepatol"},{"key":"644_CR137","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3727\/105221617X15124844266408","volume":"18","author":"DJ Van Der Windt","year":"2018","unstructured":"Van Der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The effects of physical exercise on fatty liver disease. Gene Expr. 2018;18:89. https:\/\/doi.org\/10.3727\/105221617X15124844266408.","journal-title":"Gene Expr"},{"key":"644_CR138","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.3748\/WJG.15.3462","volume":"15","author":"S Mueller","year":"2009","unstructured":"Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: A frequently underestimated combination. World J Gastroenterology: WJG. 2009;15:3462. https:\/\/doi.org\/10.3748\/WJG.15.3462.","journal-title":"World J Gastroenterology: WJG"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00644-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:51:49Z","timestamp":1786690309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00644-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":138,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00644-8","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable (this article is a review and does not involve human or animal studies).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author consents to the publication of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}